These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12094379)

  • 21. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
    Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granular cell astrocytomas show a high frequency of allelic loss but are not a genetically defined subset.
    Castellano-Sanchez AA; Ohgaki H; Yokoo H; Scheithauer BW; Burger PC; Hamilton RL; Finkelstein SD; Brat DJ
    Brain Pathol; 2003 Apr; 13(2):185-94. PubMed ID: 12744472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
    Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
    Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H; Kleihues P
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
    Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
    Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK
    Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J; Pang JC; Tong CY; Lau B; Yin XL; Poon WS; Jiang CC; Zhou LF; Ng HK
    Br J Cancer; 2002 Jul; 87(2):218-24. PubMed ID: 12107846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
    Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
    Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
    Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.
    Kraus JA; Koopmann J; Kaskel P; Maintz D; Brandner S; Schramm J; Louis DN; Wiestler OD; von Deimling A
    J Neuropathol Exp Neurol; 1995 Jan; 54(1):91-5. PubMed ID: 7815084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.
    Michaud K; de Tayrac M; D'Astous M; Duval C; Paquet C; Samassekou O; Gould PV; Saikali S
    PLoS One; 2016; 11(12):e0168728. PubMed ID: 28030632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal analysis of human astrocytomas.
    Morse RP; Darras BT; Ye Z; Wu JK
    J Neurooncol; 1994; 21(2):151-7. PubMed ID: 7861191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas.
    Sahm F; Koelsche C; Meyer J; Pusch S; Lindenberg K; Mueller W; Herold-Mende C; von Deimling A; Hartmann C
    Acta Neuropathol; 2012 Jun; 123(6):853-60. PubMed ID: 22588899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
    Hirose T; Ishizawa K; Shimada S
    Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
    Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.
    Bissola L; Eoli M; Pollo B; Merciai BM; Silvani A; Salsano E; Maccagnano C; Bruzzone MG; Fuhrman Conti AM; Solero CL; Giombini S; Broggi G; Boiardi A; Finocchiaro G
    Ann Neurol; 2002 Dec; 52(6):842-5. PubMed ID: 12447941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
    Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
    Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.